Akero Therapeutics (AKRO) Earnings
|
Expand Research on AKRO
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +4.1% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +5.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/12/26  |
Q425 | N/A | -$1.01 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/12/25 |
Q325 | N/A | -$0.93 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/8/25 | Q225 | -$0.86 | -$0.90 | +$0.04 | N/A | N/A | N/A |  | | Details | |
| 5/13/25 |
Q125 | -$0.90 | -$1.01 | +$0.11 | N/A | N/A | N/A | | | Details | |
| 3/13/25 |
Q424 | N/A | -$1.16 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/8/24 |
Q324 | N/A | -$0.88 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/13/24 | Q224 | N/A | -$0.83 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/9/24 | Q224 | -$0.81 | -$0.83 | +$0.02 | N/A | N/A | N/A | | | Details |
